Cargando…

Magnetic Resonance Assessment of Ejection Fraction Versus Echocardiography for Cardioverter-Defibrillator Implantation Eligibility

SIMPLE SUMMARY: Nonischemic cardiomyopathies with low left ventricular ejection fractions (LVEF) are eligible for an implantable cardioverter defibrillator. However, the guidelines do not specify which method should be used to assess LVEF. In our study we investigated the potential impact of perform...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schiau, Călin, Leucuța, Daniel-Corneliu, Dudea, Sorin Marian, Manole, Simona
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8614933/ https://www.ncbi.nlm.nih.gov/pubmed/34827101 http://dx.doi.org/10.3390/biology10111108

Ejemplares similares

Impact of cardiovascular magnetic resonance assessment of ejection fraction on eligibility for implantable cardioverter defibrillators
por: Joshi, Subodh B, et al.
Publicado: (2011)

Cardiovascular magnetic resonance: contribution to the exploration of cardiomyopathies
por: Schiau, Călin, et al.
Publicado: (2019)

Potential clinical impact of cardiovascular magnetic resonance assessment of ejection fraction on eligibility for cardioverter defibrillator implantation
por: Joshi, Subodh B, et al.
Publicado: (2012)

Selection of patients eligible for implantable cardioverter defibrillator: beyond left ventricular ejection fraction
por: Rizzello, Vittoria
Publicado: (2022)

Efficacy of an implantable cardioverter-defibrillator in patients with diabetes and heart failure and reduced ejection fraction
por: Rørth, Rasmus, et al.
Publicado: (2019)

Rare Case of Intravascular Myopericytoma—Imaging Characteristics and Review of the Literature
por: Manole, Simona, et al.
Publicado: (2022)

Eligibility for subcutaneous implantable cardioverter‐defibrillator in adults with congenital heart disease
por: Zormpas, Christos, et al.
Publicado: (2021)

Eligibility for subcutaneous implantable cardioverter-defibrillator in patients with left ventricular assist device
por: Zormpas, Christos, et al.
Publicado: (2020)

Publisher Correction to: Efficacy of an implantable cardioverter-defibrillator in patients with diabetes and heart failure and reduced ejection fraction
Publicado: (2020)

Implantable cardioverter-defibrillators /
Publicado: (1994)

Association between implanted cardioverter-defibrillators and mortality for patients with left ventricular ejection fraction between 30% and 35%
por: Wasfy, Jason H, et al.
Publicado: (2023)

Relationship between right and left ventricular function in candidates for implantable cardioverter defibrillator with low left ventricular ejection fraction
por: Jimenez-Juan, Laura, et al.
Publicado: (2017)

Deactivation of implantable cardioverter-defibrillators
por: Wan, Darryl, et al.
Publicado: (2021)

Implantation of Implantable Cardioverter Defibrillators in Kazakhstan
por: Begisbayev, Temirkhan, et al.
Publicado: (2022)

The subcutaneous implantable cardioverter-defibrillator should be considered for all patients with an implantable cardioverter-defibrillator indication
por: Tan, Jian Liang, et al.
Publicado: (2022)

Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator
por: Jazayeri, Mohammad-Ali, et al.
Publicado: (2017)

Does stress echocardiography add incremental value to baseline ejection fraction for the early identification of candidates for implantable defibrillators?
por: Muhrbeck, Josephine, et al.
Publicado: (2019)

Relation of multicenter automatic defibrillator implantation trial implantable cardioverter-defibrillator score with long-term cardiovascular events in patients with implantable cardioverter-defibrillator
por: Uslu, Abdulkadir, et al.
Publicado: (2018)

Remote Monitoring of Implantable Cardioverter Defibrillator
por: Reynolds, Dwight W, et al.
Publicado: (2006)

The Subcutaneous Implantable Cardioverter-Defibrillator: Not For All
por: Nair, Krishnakumar, et al.
Publicado: (2014)

Programming implantable cardioverter/defibrillators and outcomes
por: Horlbeck, Fritz W., et al.
Publicado: (2015)

Implantable cardioverter–defibrillator in hypertrophic cardiomyopathy
por: Sanchez, Diego Jimenez, et al.
Publicado: (2018)

Magnetic resonance imaging in patients with a subcutaneous implantable cardioverter-defibrillator
por: Keller, Jiří, et al.
Publicado: (2015)

Characteristics of Cardiac Memory in Patients with Implanted Cardioverter-defibrillators: The Cardiac Memory with Implantable Cardioverter-defibrillator (CAMI) Study
por: Haq, Kazi T., et al.
Publicado: (2021)

Mortality outcome and predictive risk factors for death in patients with heart failure and reduced ejection fraction who declined implantable cardioverter defibrillator implantation in Singapore
por: Khoo, Chun Yuan, et al.
Publicado: (2018)

Defibrillation Testing of the Implantable Cardioverter Defibrillator: When, How, and by Whom?
por: Pires, Luis A
Publicado: (2007)

Predictors of Elevated Defibrillation Threshold with the Subcutaneous Implantable Cardioverter-defibrillator
por: Do, Khuyen, et al.
Publicado: (2017)

A sustained ventricular tachycardia overlooked by subcutaneous implantable cardioverter-defibrillator but recognized by co-implanted transvenous implantable cardioverter defibrillator
por: Goto, Kentaro, et al.
Publicado: (2020)

Impairment of Quality of Life in Patients with Implanted Subcutaneous Cardioverter Defibrillator (S-ICD) Compared to Implanted Transvenous Cardioverter Defibrillator Therapy
por: Thienel, Manuela, et al.
Publicado: (2022)

Implantable Cardioverter-Defibrillator Eligibility After Initiation of Sacubitril/Valsartan in Chronic Heart Failure: Insights From PROVE-HF
por: Felker, G. Michael, et al.
Publicado: (2021)

Intrapericardial Implantation of an Implantable Cardioverter-Defibrillator in a Child
por: Seong, Yong Won, et al.
Publicado: (2011)

The Effect of Sacubitril/Valsartan on Device Detected Arrhythmias and Electrical Parameters among Dilated Cardiomyopathy Patients with Reduced Ejection Fraction and Implantable Cardioverter Defibrillator
por: Russo, Vincenzo, et al.
Publicado: (2020)

Interaction between electrical storm and left ventricular ejection fraction as predictors of mortality in patients with implantable cardioverter defibrillator: A Chinese cohort study
por: Zhai, Zhengqin, et al.
Publicado: (2022)

Implantable cardioverter-defibrillator placement among patients with left ventricular ejection fraction ≤35 % at least 40 days after acute myocardial infarction
por: Judson, Gregory L., et al.
Publicado: (2022)

Cardiac magnetic resonance outperforms echocardiography to predict subsequent implantable cardioverter defibrillator therapies in ST-segment elevation myocardial infarction patients
por: Marcos-Garcés, Víctor, et al.
Publicado: (2023)

Experiences of magnetic resonance imaging scanning in patients with pacemakers or implantable cardioverter-defibrillators
por: Han, Donghoon, et al.
Publicado: (2019)

Quality of Life in Patients with Implantable Cardioverter Defibrillators
por: Francis, Johnson, et al.
Publicado: (2006)

Perioperative Management of Patients with Implantable Cardioverter Defibrillators
por: Donnelly, Patrick, et al.
Publicado: (2007)

Electrical Storms in Patients with an Implantable Cardioverter Defibrillator
por: Song, Pil Sang, et al.
Publicado: (2011)

The use of implantable cardioverter defibrillators in pediatric patients
por: Campagnucci, V, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_cmgk54284aqgao1007o8an4i76